BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2971513)

  • 1. Concanavalin A induced suppressor activity exerted by peripheral blood mononuclear cells--with special reference to chronic inflammatory bowel disease.
    Davidsen BD
    Dan Med Bull; 1988 Jun; 35(3):201-22. PubMed ID: 2971513
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective autologous mixed-lymphocyte reaction and suppressor cell generation in patients with inflammatory bowel disease.
    Ginsburg CH; Falchuk ZM
    Gastroenterology; 1982 Jul; 83(1 Pt 1):1-9. PubMed ID: 6210596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune regulation in inflammatory bowel disease: absence of a serum inhibitor of suppressor cell function.
    Kemler BJ; Alpert E
    Clin Exp Immunol; 1980 Nov; 42(2):280-4. PubMed ID: 6451338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased suppressor cell activity in inflammatory bowel disease.
    Hodgson HJ; Wands JR; Isselbacher KJ
    Clin Exp Immunol; 1978 Jun; 32(3):451-8. PubMed ID: 308420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subpopulations, lymphoblast transformation activity, and concanavalin A-induced suppressor activity in patients with ulcerative colitis and Crohn's disease.
    Davidsen B; Kristensen E
    Scand J Gastroenterol; 1987 Sep; 22(7):785-90. PubMed ID: 2960010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G; Chastenay BF; Krawitt EL
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
    Danis VA; Heatley RV
    Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.
    Asquith P; Kraft SC; Rothberg RM
    Gastroenterology; 1973 Jul; 65(1):1-7. PubMed ID: 4720822
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
    Probert CS; Chott A; Turner JR; Saubermann LJ; Stevens AC; Bodinaku K; Elson CO; Balk SP; Blumberg RS
    J Immunol; 1996 Oct; 157(7):3183-91. PubMed ID: 8816432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous suppressor cell function in inflammatory bowel disease.
    Victorino RM; Hodgson HJ
    Dig Dis Sci; 1981 Sep; 26(9):801-6. PubMed ID: 6456877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of suppressor cells by Mycobacterium paratuberculosis antigen in inflammatory bowel disease.
    Ebert EC; Bhatt BD; Liu S; Das KM
    Clin Exp Immunol; 1991 Feb; 83(2):320-5. PubMed ID: 1825189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in T lymphocyte subpopulations in inflammatory bowel disease.
    Victorino RM; Hodgson HJ
    Clin Exp Immunol; 1980 Jul; 41(1):156-65. PubMed ID: 6969150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concanavalin A-induced suppressor activity of human lymphocyte subpopulations.
    Gergely P; González-Cabello R
    Acta Med Acad Sci Hung; 1980; 37(3):239-45. PubMed ID: 6450507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of inflammatory bowel disease.
    Stenson WF; MacDermott RP
    Year Immunol; 1988; 3():310-22. PubMed ID: 2964764
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ulcerative colitis and Crohn disease from the immunologic viewpoint].
    Storch W
    Z Gesamte Inn Med; 1993 Feb; 48(2):49-51. PubMed ID: 8465545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Functional status of intestinal t lymphocytes, regulatory mechanisms, and their variations in the course of Crohn disease and ulcerative colitis].
    Boirivant M; Marini M; Di Felice G
    Ann Ist Super Sanita; 1999; 35(2):283-9. PubMed ID: 10645662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of inflammatory bowel disease.
    Stenson WF
    Year Immunol; 1985; ():214-8. PubMed ID: 3033942
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective, blind investigation of immunological reactions in chronic inflammatory bowel disease. Suppressor activity and immune capacity.
    Davidsen B; Kristensen E
    Acta Med Scand; 1986; 219(1):113-24. PubMed ID: 2937257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.